Question 71

Health care professionals should be particularly observant for signs of hemorrhage when patients are receiving anticoagulants.

Anticoagulants are medications that help prevent blood clots, but they also increase the risk of bleeding. Therefore, health care professionals must closely monitor patients for any signs of hemorrhage.

A) anuria.

Anuria refers to the absence of urine production, which is not directly related to anticoagulant therapy. While renal function is important to monitor, anuria is not a specific sign that indicates complications from anticoagulant use.

B) hemorrhage.

Hemorrhage is a critical concern for patients on anticoagulants, as these medications can significantly increase the risk of bleeding. Vigilance for signs of hemorrhage, such as unusual bruising, blood in urine or stool, or prolonged bleeding from cuts, is essential in managing the safety of these patients.

C) musculoskeletal pain.

Musculoskeletal pain is a common issue among many patients for various reasons, including injury or underlying conditions. However, it is not a primary concern associated with anticoagulant therapy, making it less relevant in this context.

D) polyuria.

Polyuria is characterized by the excessive production of urine, which does not have a direct correlation to anticoagulants. While it can be a symptom of other medical conditions, it is not a sign that health care professionals should closely monitor in patients receiving anticoagulation therapy.

Conclusion

In summary, the correct answer is B) hemorrhage, as anticoagulant therapy significantly heightens the risk of bleeding complications. Other options, such as anuria, musculoskeletal pain, and polyuria, do not specifically relate to the safety concerns in patients on these medications, highlighting the importance of monitoring for signs of hemorrhage as a critical aspect of patient care.